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Objective: To compare the effects of two surgical procedures for the correction of anterior 
vaginal wall prolapse (AVWP) on the lower urinary tract symptoms (LUTS) using symptom 
questionnaires and quality of life (QoL).
Materials and Methods: One hundred women with Pelvic Organ Prolapse Quantification 
stage (POP-Q) ≥ 2 were randomly distributed in two preoperatory groups. The first group 
(mesh) (n = 45) received a polypropylene mesh (PM) implant and the control group (n = 
55) was submitted to anterior colporraphy with or without synthetic sling. Postoperatory 
follow-up was done after 12 months. The primary objective was to compare the effect of 
the surgeries on LUTS using the final scores of the International Consultation on Inconti-
nence Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) and Overactive Bladder 
Questionnaire (OAB-V8), as well as the analysis of the incapacitating urinary symptoms 
and “de novo” urinary symptoms after 12 months of surgery in both groups.
Results: Although there was a different number of women in each group, randomization 
was adequate, resulted in homogeneous groups that could be compared regarding socio 
demographic, clinical and gynecological (POP-Q) variables. Patients of both groups showed 
improvements regarding LUTS and QoL, whether using polypropylene mesh or not, based 
on the final scores of the ICIQ-UI SF and OAB-V8 questionnaires after 12-month follow-
-up. There were few incapacitating and “de novo” urinary symptoms, without any signifi-
cant statistical difference between both groups after 12 months of surgery.
Conclusion: There was a general improvement of LUTS and QoL in both groups after 
12-month follow-up. However, there was no significant difference of LUTS, as well as 
the more incapacitating and “de novo” urinary symptoms between both groups after 12 
months of surgery.
INTRODuCTION
The decision to perform a prophylactic 
anti-incontinence surgery in women with suspi-
cion of a hidden stress urinary incontinence (SUI) 
during a surgery for correction of pelvic organ pro-
lapse (POP) is controversial. At present, this appro-
ach has been recommended during evaluation of 
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hidden urinary stress incontinence at pre-operatory 
period (1). However, this evaluation not always 
identifies correctly women who need prophylactic 
anti-incontinence surgery during correction of an-
terior vaginal wall prolapse (AVWP) (2). The use of 
polypropylene mesh (PM) in surgeries for genital 
dystopia has been popularized in the last years, 
throughout standardization of the surgical tech-
nique, with good anatomical results in short and 
medium terms. However, based on the recent re-
ports of complications related to the use of mesh 
in those surgeries, the Food and Drug Administra-
tion (FDA) has been warning surgeons about the 
complications of the use of polypropylene mesh 
in vaginal reconstructive surgeries (3). In view of 
the relative low number of publications about this 
subject, we proposed a comparative study betwe-
en both surgical techniques for AVWP correction, 
analyzing the results regarding lower urinary tract 
symptoms (LUTS).
MATERIALS AND METhODS
Study Design, objectives and patient selection
 This is a prospective, randomized, single-
-blinded and controlled study to evaluate the 
outcomes of two surgical procedures to correct 
AVWP. The evaluation of the anatomical cure 
(POP-Q) and complications will be discussed sepa-
rately (Part I).
 From February 2008 to December 2010, 
122 women attending the Ambulatory of Urogy-
necology, Health Secretary of Jau, SP, Brazil, were 
selected.  Women 45 years old or older, with AVWP 
≥ II (POP-Q Stage) (4) without previous surgical 
correction or with previous surgical treatment of 
AVWP without the use of PM were selected. Ex-
clusion criteria were women receiving oncological 
treatment with altered Papanicolau Smear exam 
or with uterine bleeding, with genital or acute uri-
nary infection, patients who did not commit to 
ambulatory follow-up or those that refused the 
written informed consent.
Patients, study location and eligibility criteria
  Methods, definitions and units 
were used according to the standards of the Inter-
national Continence Society (ICS) and Internatio-
nal Urogynecology Association (IUGA) (5). Data 
included age (years), parity, number of deliveries, 
body mass index (BMI - Kg/m2), hormonal sta-
tus (pre-, peri and postmenopausal), history of 
previous histerectomy (yes or no) and POP stage 
(POP-Q). Clinical categories were used to evalu-
ate the hormonal status. Women with more than 
12 months of amenorrhea were considered in the 
post-menopausal period. Analysis of lower urinary 
tract symptoms included SUI, urge-incontinence, 
frequency and voiding difficulty. The study was 
approved by the Ethical Committee of the Federal 
University of Sao Paulo - UNIFESP - under the 
number 1335/08.
 The same group of authors idealized, de-
veloped and conducted all steps of the study, in-
cluding follow-up. PM supplies did not donate 
funds or surgical devices samples for the study.
Evaluations
 Objective:
  POP-Q was used to measure (in 
centimeters) the supporter of several anatomical 
aspects of the vaginal canal (4);
 Urinary Incontinence Evaluation
  Objective: During preoperatory 
period, patients were submitted to urodynamic 
evaluation (Dynapack MPX 816, Dynamed, Sao 
Paulo, Brazil) including spontaneous uroflowme-
try, cystometry, pressure/flow studies and post-
-voiding residue. SUI was analyzed at the end of 
cystometry, with a reasonable full bladder. SUI 
was considered in the event of any urinary loss 
during straining. The same maneuver was repe-
ated after reduction of AVWP and placement of 
a gauze tampon deep in the vagina in order to 
verify hidden urinary incontinence (2). Idiopathic 
detrusor overactivity (IDO) was considered in the 
presence of spontaneous or elicited involuntary 
detrusor contractions during cystometry. Urody-
namics evaluation followed the recommendations 
of the Urodynamic Society (6).
Subjective:
  International Consultation on 
Incontinence Questionnaire - Urinary Inconti-
nence Short Form (ICIQ-UI SF): This is a self-
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-administered questionnaire, translated and va-
lidated for Portuguese that evaluates the impact 
of UI on quality of life (QoL). The first three 
questions evaluate frequency, severity and uri-
nary incontinence impact on QoL. The fourth 
question includes eight items related to causes 
or situations when UI occurs. Final score is the 
sum of questions 3, 4 and 5 and ranges from 
0 to 21, and the impact on QoL of UI is worse 
as the score rises (7). The presence of SUI was 
evaluated through item 3 of question 4 (Do you 
lose urine during coughing or sneezing?).
  Overactive Bladder Question-
naire - V8: This is a self-administered ques-
tionnaire, validated and translated for Portu-
guese with eight questions (8) that evaluates 
lower urinary tract symptoms and help the cli-
nical diagnosis of overactive bladder syndrome 
(OAB). Each question has a 6-point Likert scale 
that ranges from “never” (score = 0) to “very 
much” (score = 6). Final score varies from 0 
to 48 and the higher the score, the worse the 
symptoms. The presence of irritative lower 
urinary tract symptoms like “frequency” and 
“urge-incontinence” was respectively evaluated 
through questions 1 and 8. The answers were 
considered positive when the patients answered 
“very” or “very much”.
  Voiding difficulty: It was evalu-
ated through a positive answer (not, a little, mo-
derately or much) for the question: “Do you have 
voiding difficulty?” using the scale of symptoms 
of the King’s Health Questionnaire (KHQ), trans-
lated and validated for Portuguese (9).
Objectives
 Primary: final scores of the ICIQ-UI SF 
and OAB-V8 questionnaires after 12-month 
follow-up:
  ICIQ-UI SF
   Final score = 0 (no UI)
   Final score ≥ 3 (presence 
of UI)
  
  OAB-V8
   Final score = 0 (no irrita-
tive low urinary tract symptoms)
   Final score ≥ 1 (presence 
of irritative lower urinary tract symptoms)
Secondary: Evaluation of more incapa-
citating urinary and “de novo” symptoms, such 
as frequency, voiding difficulty, urge-incon-
tinence, and stress urinary incontinence after 
12-month follow-up.
Polypropylene mesh kit description
NAZCA TC KIT (Promedon, Cordoba, Ar-
gentina)
NAZCA TC kit includes type 1 PM, mono-
filament, with macropores varying from 0.5 to 1 
mm diameter and density of 60.5 g/m2. PM body 
contains 6 mm diameter holes in order to facilitate 
integration with host tissue, lowering the amount of 
synthetic implanted material and local inflammatory 
reaction. Four self-adjustable tapes of the same ma-
terial arise from the body, ending in needle connec-
tors. Two of these tapes are passed through prepubic 
insertion of the needles (vaginal suprapubic route) 
and the other two (posterior) are passed by the nee-
dles through transobturator route. The needles reach 
the tendineous arcs, close to the ischial spines bila-
terally (10).
Surgical procedure
All surgeries were performed under spi-
nal anesthesia and all patients received 2g of IV 
cephazolin for prophylaxis. Bladder catheter was 
inserted in the beginning of the surgery and re-
moved in the first postoperatory day. As needed, 
concurrent procedures were performed, such as 
posterior colporraphy and vaginal hysterectomy. 
Patients of the control group with urodynamic 
diagnosis of SUI were concurrently treated with 
retropubic synthetic sling. All patients were ope-
rated by the same surgical team (JTNT, MMMT). 
Before the beginning of the study, the surgeons 
performed two surgeries using NAZCA TC in order 
to reduce the learning curve impact on the final 
results.
NAZCA TC surgical procedure 
With the patient in the lithotomy position, 
a midline incision in the anterior vaginal wall 
is performed, from the midurethra to the uterine 
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cervix. The dissection is continued until the is-
chial-pubic branch and inferior edge of the pubic 
symphysis. The needles are passed from the vaginal 
incision to the suprapubic region in order to alloca-
te the prepubic tapes. After removing the handle of 
the needle on the vaginal side, it is reconnected on 
the suprapubic side of the needle. After the anterior 
tape of the NAZCA TC is connected, the needle is 
gently pulled and the maneuver is finished with the 
exteriorization of the anterior tape in the suprapu-
bic region. The same maneuver is made in the other 
side, creating a bracket of the median urethra. The 
transobturator needle is passed through the genito-
femoral fold 2 cm laterally and 3 cm inferiorly to the 
urethral meatus. This needle must reach the region 
close to the ischial spine, exteriorized through the 
vaginal incision. The posterior tapes are connected 
to the needle and removed, exteriorizing through the 
genitofemoral fold incision. This maneuver is repe-
ated in the contralateral side. The body of the mesh 
is fixed with absorbable sutures in the region of the 
cardinal ligaments and in the region of the cervical 
ring. The four tapes are adjusted in order to correct 
AVWP without folds or material redundancy. The 
excess is discharged before the closure of the ante-
rior vaginal wall incision, performed with separated 
sutures of Vycril 2-0 (10).
Traditional anterior colporraphy
 With the patient in the lithotomy position, 
a midline incision on the anterior vaginal wall is 
performed, from the midurethra to the uterine cer-
vix. The anterior vaginal wall is separated from the 
vesicovaginal fascia and from the bladder using 
pointless detachment. This maneuver identifies oc-
casional lesion (relaxation or rupture) of the vesico-
vaginal fascia. In case of central defect it is corrected 
using plication of the fascia along the midline using 
separated sutures of Vycril 2-0. Lateral defects are 
treated using localized sutures with Vycril 2-0 (11).
Treatment of SUI for the Control Group
 Patients from the control group with a pre-
operatory urodynamic diagnosis of SUI were conco-
mitantly treated with retropubic synthetic sling (12). 
All patients were treated by the same surgical team, 
and all members had surgical experience with uro-
gynecological procedures.
Statistical analysis
In order to evaluate preoperatory differen-
ces between both groups, chi-square test was used 
for cathegoric variables and t-Student test for conti-
nuous variables with normal distribution. All nume-
rical data were expressed as mean ± standard devia-
tion (SD). Paired t-test was used to detect differences 
between pre and postoperatory periods. The signifi-
cance level adopted was 5%.
 
Sample size calculation
The sample size was estimated upon litera-
ture data (1, 11). It was expected anatomical failure 
after 12-month follow-up of 38% for control group 
and 12% for mesh group. In order to detect this di-
fference (bilateral test), with 0.05 level of significan-
ce and power of the test 80%, 42 women should be 
allocated at least in each group. With an estimate 
of 10% loss after 12-month follow-up, a total of 92 
women were randomized. The sample was increased 
to 100 women in order to consider a 20% loss of 
follow-up after 24 months.
Randomization and blinding
This trial adopted single-blind masking to 
reduce bias derived from the knowledge of the pa-
tients about which procedure she was submitted. 
Randomization based in a single sequence of 
random tasks is called simple randomization. This 
technique maintains complete randomization of a 
single subject in a determined group, with adequate 
balance, mainly in groups with more than 100 indi-
viduals (13). Randomization was made by simple ra-
ffle few minutes before surgery when the result was 
informed to the surgical team, in order to proceed 
with the designed surgery.
 Women were randomly distributed in two 
groups: Mesh group (M) (n = 45) that used PM im-
plant and Control group (C) (n = 55), treated with 
traditional anterior colporraphy ± suburethral syn-
thetic sling when needed.
 Figure-1 shows details of patient selection, 
including randomization and the final number of 
evaluated patients after 12-month follow-up in both 
groups.
 Concurrent surgeries were performed accor-
ding patient’s individual needs. Postoperatory eva-
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luation was performed after 12 months of surgery. 
The informed consent was read and signed by all 
patients before the beginning of the study.
RESuLTS
During the preoperatory period, both groups 
were homogeneous regarding age, parity, number 
Figure 1 – Patient flow and randomization 
ELIGIBILITY  (n=122)
EXCLUDED (n=22) 
 Not meeting inclusion criteria (n=15) 
 Refuse to participate (n=7) 
RANDOMIZATION (n=100)
MESH GROUP (M) (n=45) CONTROL GROUP (C) (n=55) 
Not assessed (n=2) 
 Dead (n=1) 
 Lost follow-up (n=1) 
MESH GROUP 
(n= 43) 
CONTROL GROUP 
  (n=54) 
ASSESSED AT 12-MONTH FOLLOW-UP
Not assessed (n=1) 
 Lost follow-up (n=1) 
Figure 1 – Patient flow and randomization
of deliveries, BMI, hormonal status, previous hys-
terectomy and POP stage, indicating an adequate 
randomization effect (Table-1). Table-2 shows the 
pre- and postoperatory POP-Q measures.
 There was no significant statistical differen-
ce among the POP-Q measures between the groups 
during the preoperatory period. There was a statis-
tically significant difference in all POP-Q values 
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Table 1 - Demographic characteristics of the Mesh and Control groups during preoperatory period (n=100)
Demographic characteristics Mesh (n = 45) Control (n = 55) p-value
Age (years)
Mean (SP) 66.8 (9.2) 63.4 (9.5) 0.08*
Interval (min/max) 53-84 48-84
Parity
Nulliparous n (%) 0 (0) 3 (5.5) 0.94*
Multiparous n (%) 45 (100) 52 (94.5)
Number of deliveries
Mean (SD) 4.2 (2.6) 4.2 (2.7) 0.94*
Interval (min/max) 1-14 0-12
BMI (kg/m2)
Mean (SD) 27.5 (5.4) 27.8 (4.9) 0.76*
Interval (min/max) 17-42 16-39
hormonal status
Pre-menopausal (%) 2 (4.4) 0 (0) 0.86**
Per-menopausal (%) 0 (0) 1 (0.2)
Post-menopausal (%) 43 (95.6) 54 (99.8)
Previous hysterectomy
Yes (%) 3 (6.7) 6 (10.9) 0.41**
No (%) 42 (93.3) 49 (89.1)
POP stage (POP-q)
II (%) 10 (22.2) 19 (34.5) 0.32**
III (%) 28 (62.2) 31 (56.4)
IV (%) 7 (15.6) 5 (9.1)
urodynamic parameters
SUI/hidden SIU (%) 6 (13.3) 12 (21.8) 0.40
Idiopathic detrusor overactivity (%) 26(58) 35(63) 0.69
Post-voiding urinary residual (mL)
Mean (± SD) 29 (50) 31 (69) 0.87
SuI = Stress urinary incontinence
hidden SuI = Hidden stress urinary incontinence
Values = mean ± SD (standard deviation), confidence interval, frequency (n), percentage (%)
* Student t test for independent samples
** Qui-square test
between the pre- and postoperatory values in each 
particular group, demonstrating that both techni-
ques were able to improve anatomical parameters. 
However, there was a significant statistically diffe-
rence of the Aa and Ba points during the posto-
peratory period between M and C groups. Table-3 
shows the results of QoL impact of UI according to 
the final score of ICIQ-UI SF and LUTS evaluated by 
the final score of OAB-V8 at pre and postoperatory 
periods after 12 months. The most incapacitating 
effects of each surgery upon LUTS evaluated du-
ring pre- and postoperatory periods are shown at 
Table-4. The “de novo” symptoms of lower urinary 
tract in both groups after 12 months of surgery are 
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Table 2 - POP-q measurements in centimeters ± standard deviation (SD) at pre and postoperatory periods from Mesh and Control groups
Mesh Control pa
Aa
Pre-op 1.47 (1.61) 1.38 (1.78) 0.81
Post-op -2.39 (0.82) -1.59 (1.01) < 0.0001
pb < 0.0001 < 0.0001
Ba
Pre-op 3.38 (2.50) 2.55 (2.50) 0.10
Post-op -2.46 (0.70) -1.57 (1.04) < 0.0001
pb < 0.0001 < 0.0001
C
Pre-op -1.44 (5.10) -1.56 (4.90) 0.90
Post-op -6.44 (1.14) -6.70 (1.34) 0.32
pb < 0.0001 < 0.0001
D
Pre-op -2.78 (5.54) -3.80 (4.89) 0.36
Post-op -7.6 (0.66) -7.8 (1.30) 0.84
pb 0.0006c < 0.0001
Ap
Pre-op -0.58 (1.87) -0.67 (1.97) 0.81
Post-op -2.74 (0.66) -2.67 (1.34) 0.74
pb < 0.0001 < 0.0001
Bp
Pre-op 0.42 (3.33) 0.18 (2.90) 0.70
Post-op -2.74 (0.66) -2.79 (0.53) 0.69
pb < 0.0001 < 0.0001
Gh (genital hiatus)
Pre-op 4.70 (1.10) 4.80 (1.30) 0.65
Post-op 2.63 (0.69) 2.76 (0.64) 0.34
pb < 0.0001 < 0.0001
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Table 3 - Evaluation of final scores of ICIq-uI SF and OAB-V8 questionnaires at the pre- and postoperatory periods of patients 
from Mesh and Control groups. Values presented as mean ± SD.
Mesh Control pa
ICIq-uI SF Final score (0-21 interval)
Preop 9.2 (± 8.4) 11.2 (± 7.6) 0.22
Postop 3.5 (± 5.1) 4.6 (± 6.3) 0.36
pb 0.0003 < 0.0001
OAB-V8 Final score (0-48 interval)
Preop 14.95 (± 12.37) 20.38 (± 12.56) 0.03
Postop 3.3(± 6.2) 6.2 (± 8.8) 0.07
pb < 0.0001 < 0.0001
ICIq-uI SF = International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form
OAB-V8 = Overactive Bladder Questionnaire - V8
a t Student test for independent samples
b t Student test for paired samples
shown at Table-5. One patient of the M group and 
two patients of the C group had SUI in the initial 
postoperatory period and all were treated with a 
retropubic synthetic sling, and all were considered 
cured based upon subjective evaluation after 12 
months of surgery.
DISCuSSION
During the preoperatory period, both groups 
were homogeneous regarding age, parity, number 
of deliveries, BMI, hormonal status, previous hys-
terectomy and POP stage, indicating an adequate 
PB (perineal body)
Pre-op 2.70 (0.84) 2.70 (0.77) 0.71
Post-op 4.00 (0.62) 4.04 (0.77) 0.80
pb < 0.0001 < 0.0001
TVL (total vaginal length)
Pre-op 9.35 (1.04) 9.40 (1.03) 0.81
Post-op 8.23 (0.87) 8.69 (1.47) 0.08
pb < 0.0001 < 0.0001
POP-q = Pelvic organ prolapse quantification
a Student t test for independent samples 
b Student t test for paired samples
c Student t test for paired samples (analysis of patients with point D after the surgery)
c o n t i n u a t i o n
IBJu | treatment of anterior vaginal wall prolapse - part ii
539
Table 5 – Surgery effect on “de novo” lower urinary tract symptoms after 12-month  follow-up, in Mesh and Control groups. 
Values expressed in frequency and percentage (%).
“De novo” incapacitating lower urinary tract symptoms Mesh
(n = 43)
Control
(n = 54)
P*
Frequency 2 (4.6) 3 (5.5) 0.7933
Voiding difficulty 0 (0) 0 (0) 1.0000
Urge-urinary incontinency 1 (2.3) 4 (7.4) 0.5078
Stress urinary incontinency 2 (4.6) 3 (5.5) 0.7723
*Student t test for paired samples
Table 4 – Surgery effect on the most incapacitating lower urinary tract symptoms comparing pre- and postoperatory periods 
after 12 months of Mesh and Control groups. Values expressed as frequency and percentage (%).
Lower urinary tract 
most incapacitating 
symptoms
Group Mesh
n (%) 
Group Control
n (%)
Pre-operatory 
(n = 45)
12-month postopera-
tory (n = 43)
P*
Pre-opera-
tory (n = 55)
12-month posto-
peratory (n = 54)
P*
Frequency 20 (44.4) 5 (11.6) 0.0015 27 (49.1) 7 (12.9) 0.0001
Voiding difficulty 6 (13.3) 0 (0.0) 0.0396 11 (20) 0 (0) 0.0016
Urge-urinary
incontinence
22 (48.9) 7 (16.3) 0.0025 30 (54.4) 8 (14.8) < 0.0001
SUI 8 (17.8) 0 (0.0) 0.0100 12 (21.8) 1 (1.8) 0.0035
* Student t test for paired samples
randomization effect (Table-1). Table-2 shows the 
pre- and postoperatory POP-Q measures.
 There was no significant statistical diffe-
rence among the POP-Q measures between the 
groups during the preoperatory period. There was 
a statistically significant difference in all POP-Q 
values between the pre- and postoperatory values 
in each particular group, demonstrating that both 
techniques were able to improve anatomical pa-
rameters. However, there was a significant statis-
tically difference of the Aa and Ba points during 
the postoperatory period between M and C groups. 
Table-3 shows the results of QoL impact of UI ac-
cording to the final score of ICIQ-UI SF and LUTS 
evaluated by the final score of OAB-V8 at pre and 
postoperatory periods after 12 months. The most 
incapacitating effects of each surgery upon LUTS 
evaluated during pre- and postoperatory periods 
are shown at Table-4. The “de novo” symptoms of 
lower urinary tract in both groups after 12 mon-
ths of surgery are shown at Table-5. One patient 
of the M group and two patients of the C group 
had SUI in the initial postoperatory period and all 
were treated with a retropubic synthetic sling, and 
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all were considered cured based upon subjective 
evaluation after 12 months of surgery.
CONCLuSIONS
Although the anatomical rate cure of the 
AVWP was superior in the group treated with poly-
propylene mesh after 12 months of surgery, this 
significant anatomical difference did not result in a 
subjective difference of the presence of LUTS. Both 
procedures were able to improve LUTS, with low rate 
of “de novo” urinary symptoms.
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